In Brief
BCL6 overexpression contributes to the pathobiology of diffuse large B cell lymphoma (DLBCL). Sun et al. find that the co-chaperone aryl hydrocarbon receptor interacting protein (AIP), whose high expression is associated with reduced survival of DLBCL patients, helps maintain BCL6 expression by facilitating the removal of ubiquitin from BCL6.
INTRODUCTION
Chaperone molecules play a crucial role in cellular homeostasis, stabilizing labile proteins during periods of cellular stress. Heat shock protein 90 (HSP90) is central to the maintenance of cellular homeostasis (Taipale et al., 2010) , and studies have indicated that HSP90 can bind to 60% of the human kinome and 30% of E3 ubiquitin ligases (Schopf et al., 2017; Taipale et al., 2014) .
Co-chaperone proteins assist chaperone molecules in their supply and binding of specific client proteins to chaperone molecules (Trepel et al., 2010) , yet the precise molecular function by which co-chaperones of HSP90 operate is still poorly understood (Schopf et al., 2017) .
Aryl hydrocarbon receptor (AHR) interacting protein (AIP) is a conserved co-chaperone protein that binds to many proteins, including AHR and HSP90 (Stockinger et al., 2014; Trivellin and Korbonits, 2011) . Individuals carrying monoallelic loss-of-function mutations in AIP (AIP carriers) are predisposed to youngonset, aggressive, usually growth-hormone-secreting pituitary adenomas that often result in acromegalic gigantism (Caimari and Korbonits, 2016; Vierimaa et al., 2006) . Our group set out to understand the function of AIP in regulating adaptive immune responses.
Because of the well-described role of AHR regulating T helper 17 (T H 17) cells (Li et al., 2011; Veldhoen et al., 2008) , we started to examine the function of AIP on T cells and used the Rag1
Cre/+ mouse strain to study its function in T cells. Unexpectedly, however, we noticed that deletion of Aip had an effect on B cells, and we sought to investigate this function in more detail. Germinal centers (GCs) are structures within secondary lymphoid tissues that are vital for the development of effective adaptive immune responses against pathogens (Allen et al., 2007; Victora and Nussenzweig, 2012) . GCs are challenging environments for lymphocytes. B cells, upon activation, enter GCs where they undergo rapid proliferation, class switch recombination, somatic hyper-mutation, and affinity maturation, all of which place considerable genotoxic stress on B cells (Allen et al., 2007; Victora and Nussenzweig, 2012) . Inhibitors of HSP90 have been shown to be effective in inducing apoptosis of B cell lymphomas that have a GC origin and overexpress B cell lymphoma-6 (BCL6) protein (Cerchietti et al., 2009) .
BCL6 is a master regulator of GC B cell phenotype (Bunting et al., 2016; Dent et al., 1997; Ye et al., 1997) . By repressing transcription of pro-apoptotic genes such as TP53 (Basso and DallaFavera, 2015) , BCL6 enables GC B cells to tolerate genotoxic stress as they undergo rapid proliferation with somatic hypermutation and class switch recombination (Basso and DallaFavera, 2015) . Accordingly, BCL6 upregulation is commonly found in B cell lymphomas of GC origin (Baron et al., 1993; Basso and Dalla-Favera, 2015) .
Here, we deleted Aip in mouse B cells, which led to suboptimal adaptive immune responses, via altered AKT signaling and by controlling the expression of BCL6 in GC B cells. We show that AIP protects BCL6 from E3 ubiquitin ligase FBXO11-induced proteasomal degradation via binding the deubiquitinase UCHL1. Together, these results demonstrate AIP as a positive regulator of BCL6. Figures 1A-1C) .
RESULTS

AIP Regulates Adaptive Immune Responses
We sought to determine whether Aip fl/fl Cre + mice had a defect in the ability to generate high-affinity antibodies. Mice were immunized with (4-hydroxy-3-nitrophenyl)-acetyl (NP)-keyhole limpet hemocyanin (KLH) precipitated to aluminum hydroxide (alum), and 2 weeks later, the capacity of serum immunoglobulins to bind to high-valency antigen (NP 25 ) and low-valency antigen (NP 5 ) was examined (Capasso et al., 2010) . No difference was detected between the Aip fl/fl Cre + and Cre À mice in the generation of low-affinity antibody against NP-KLH ( Figure 1D ). However, there was a significant reduction in the ability of Aip fl/fl Cre + mice to produce high-affinity antibody that could bind to NP 5 (p = 0.0002) ( Figure 1E ), and consequently, the ratio between NP 5 and NP 25 specific antibodies between Aip fl/fl Cre + and Cre À mice was low (p = 0.026) ( Figure 1F ).
AIP Regulates GC Formation
The ability to make antibody responses against T cell-dependent antigens is dependent upon B cell differentiation into GC B cells (Victora and Nussenzweig, 2012 Figure S5 . Scale bars, 100 mm. Results are from two or three independent experiments with two to four animals per experiment. *p < 0.05; **p < 0.01.
we also observed decreased GC B cells and BCL6 expression in peripheral lymph nodes although there was an increase in GC B cells from Peyer's patches in Cre + mice ( Figure S2A ). Differences in GC B cells may be the result of altered B cell development or the type of B cells produced. Examination of naive, marginal zone and follicular B cell subsets revealed no difference between Cre À and Aip fl/fl Cre + mice ( Figures S3A-S3D ).
BCL6 has been reported to contribute to B cell lymphopoiesis (Duy et al., 2010) . Consequently, we examined developing B cell subsets in the bone marrow of Cre À and Aip fl/fl Cre + mice but found no significant differences ( Figure S3C ). Figure S3E ), indicating that deficiency of AIP did not alter the production of antibodies or isotype switching. As AIP was originally described as a co-chaperone for AHR (Meyer and Perdew, 1999) , we examined Ahr fl/fl mice crossed with Rag1 Cre/+ mice to determine if they had a similar phenotype. In agreement with a publication studying the role of AHR in B cells (Villa et al., 2017) len et al., 2007; Mesin et al., 2016; Victora and Nussenzweig, 2012) . DZ and LZ GC B cells can be distinguished by flow cytometry using the markers including CXCR4 (DZ) and CD86 (LZ) (Victora et al., 2010 (Calado et al., 2012) . Mice were immunized with SRBCs, and 10 days later, the percentage of GC (GL7 + CD95 + ) B cells and the expression of BCL6 were determined. As predicted, conditional deletion of Aip in GC B cells resulted in a lower percentage of GC B cells with a lower expression of BCL6 ( Figures 4A-4D ) and a decreased ratio of DZ to LZ GC B cells ( Figure 4E ) and decreased anti-SRBC IgG ( Figure 4F ). Together, these results indicated that AIP regulated GC B cells and BCL6 expression independently of T cells.
AIP Protects BCL6 from FBXO11-Mediated Proteasomal Degradation
We sought to investigate the mechanism by which AIP sustains BCL6 expression in GC B cells. The E3 ligase containing F box protein O11 (FBXO11) has been shown to target BCL6 for ubiquitin-mediated proteasomal degradation (Duan et al., 2012) . This observation attracted our interest as a potential mechanism by which AIP could regulate BCL6, as AIP had previously been shown to protect AHR from ubiquitin-mediated degradation (Kazlauskas et al., 2000) and AIP has recently been found to bind to FBXO3 (Herná ndez-Ramírez et al., 2016) . We hypothesized that AIP was protecting BCL6 from ubiquitin-mediated proteasomal degradation via FBXO11.
Immunoprecipitation (IP) analysis of HEK cells transfected with MYC-tagged AIP and FLAG-tagged FBXO11 revealed that AIP could bind to FBXO11 and BCL6, thereby revealing a potential mechanism of action ( Figures 5A and 5B ). Ubiquitin E3 ligases are often found in association with deubiquitinases (DUBs) of the same substrate (Komander et al., 2009) . We therefore wanted to know if AIP associated with any DUBs that might regulate BCL6 expression. Mass-spectrometry analysis had revealed that AIP could bind to the DUB UCHL1 (Herná ndez- Ramírez et al., 2016) . UCHL1 is induced in GC B cells and cooperates with BCL6 to promote a mouse model of lymphoma and is associated with an aggressive subset of diffuse large B cell lymphoma (DLBCL) (Bedekovics et al., 2016; Hussain et al., 2010) . We hypothesized that AIP might support the expression of BCL6 by binding UCHL1 and support the deubiquitination of BCL6.
Using the functionally relevant DLBCL cell line OCI-LY7, we found that AIP could bind to UCHL1 ( Figure 5C ) and that UCHL1 could bind to BCL6 ( Figure 5D ), indicating that UCHL1 could be responsible for maintaining BCL6 expression. In agreement with Duan et al. (2012) , we found that OCI-LY7 cells expressed FBXO11, although interestingly, using these cells, we found that FBXO11 could not directly bind to BCL6 ( Figure 5E ). To determine if FBXO11-mediated degradation of BCL6 could be modulated by AIP, we transfected HEK cells with epitopetagged FBXO11, BCL6, AIP, and ubiquitin plasmids. The addition of AIP reduced FBXO11-mediated ubiquitin conjugation to BCL6. The absence of AIP resulted in an increase in BCL6 ubiquitination (in the presence of FBXO11) and subsequently decreased BCL6 expression, recapitulating what we observed in Aip-deficient B cells ( Figure 5F ). BCL6 has not been described as being a substrate for UCHL1, so we tested whether UCHL1 could deubiquitinate BCL6. Transfection of HEK cells revealed that UCHL1 could deubiquitinate BCL6 only in the presence of AIP ( Figure 5G ), indicating that AIP regulated the function of UCHL1. To confirm the IP results, we performed confocal microscopy using the OC1-LY7 lymphoma cell line. AIP co-localized with BCL6, UCHL1, and FBXO11. BCL6 co-localized with FBXO11 and, to a greater extent, UCHL1 ( Figure 5H ). Together, these results revealed the mechanism by which AIP regulated BCL6 expression in GC B cells. AIP expression was higher in DLBCLs than in other cancers and tumors ( Figure 6A ). Histological analysis of primary DLBCL biopsy samples revealed that AIP expression was significantly increased compared to control (reactive lymph node) samples (p < 0.0001) ( Figure 6B ). Data obtained from genomicscape (http://www.genomicscape.com/) revealed that DLBCL patients with high AIP expression had significantly (p = 0.002) reduced survival compared to those with low AIP expression, indicating that increased AIP expression contributed to the morbidity of DLBCL ( Figure 6C ). Western blot analysis revealed that AIP was expressed in a number of DLBCL cell lines and that its expression matched BCL6 expression ( Figures 6D and 6E ).
AIP Is Overexpressed in Human DLBCLs
To determine if knockdown of AIP in lymphoma cells affects their viability, we performed lentiviral knockdown of AIP in OC1-LY7 DLBCL lymphoma cells. Knockdown of AIP in OC1-LY7 cells resulted in decreased AIP and BCL6 expression and decreased the viability of the DLBCL lymphoma cells ( Figure 6F ).
Based upon these results, we propose that AIP positively regulates BCL6 expression by binding to the DUB UCHL1, thereby preventing FBXO11-mediated ubiquitination of BCL6 and contributing to the maintenance of BCL6 expression in GC B cells and DLBCLs ( Figure 6G ).
DISCUSSION
Lymphocytes need to maintain cellular homeostasis as they navigate a range of genotoxic events and environments. A particularly challenging environment is within GCs, where B cells undergo rapid proliferation, class switching, and somatic hypermutation. How B cells preserve cellular homeostasis in this environment is still not completely clear.
We provide evidence that AIP is required for mounting immune responses against T cell-dependent and, to a lesser extent, T cell-independent antigens and the generation of high-affinity antibodies. Consequently, we found that (Sato et al., 2000) , and UCHL1 has also been found to regulate AKT signaling (Hussain et al., 2010) , and we are currently determining how AIP regulates AKT signaling.
AIP is a co-chaperone for AHR (Kazlauskas et al., 2000; Lees et al., 2003) . We were therefore surprised to find that conditional deletion of Ahr in B and T cells did not match the phenotype we observed in Aip fl/fl Cre + mice. This indicated that AIP was acting independently of AHR to regulate GC B cells. This finding is supported by Villa et al., who showed that AHR supported B cell proliferation but was not necessary for T cell-dependent or independent immune responses (Villa et al., 2017) . However, a recent publication reports that AHR was important in suppressing T cell-dependent and T cell-independent immune responses (Vaidyanathan et al., 2017) . The reasons for the different responses from Ahr null B cells are not clear at present. As BCL6 is an important oncoprotein, there is considerable interest in how it is regulated. BCL6 expression can be controlled via post-translational mechanisms, including phosphorylation (Niu et al., 1998) , mRNA stability, and nuclear export by eIF4Ae (eukaryotic translation initiation factor 4E) (Culjkovic-Kraljacic et al., 2016), in response to DNA damage (Phan et al., 2007) and stabilization by HSP90 (Cerchietti et al., 2009 ). Mitogen-activated protein kinase (MAPK) signaling following B cell receptor stimulation has been shown to be involved in the degradation of BCL6 (Niu et al., 1998) . We saw no evidence of increased ERK signaling in Aip null B cells compared to wild-type B cells following anti-IgM stimulation, suggesting that this is not the mechanism by which AIP regulated BCL6 expression.
FBXO11 has been found to target BCL6 for ubiquitin-mediated degradation and mutations in FBXO11 associated with lymphoma (Duan et al., 2012) . We found that AIP and the FBXO11-containing E3 ligase complex co-immunoprecipitation Figure 5 . AIP Protects BCL6 from FBXO11-Mediated Proteasomal Degradation (A) HEK293T cells were transfected with either a FLAG-tagged FBXO11 or empty vector (EV-FLAG), together with MYC-tagged AIP. A majority of the whole-cell extracts (WCEs) were subjected to immunoprecipitation (IP) using FLAG antibody (rows 1 and 2), and the rest of the WCEs were used in immunoblotting (rows 3 and 4). (B) HEK293T cells were transfected with either FLAG-tagged BCL6 or EV-FLAG, together MYC-tagged AIP (Leontiou et al., 2008) . A majority of the WCEs were subjected to IP using FLAG antibody (rows 1 and 2), the and the rest of the WCEs were used in immunoblotting (rows 3 and 4). (co-IP), and we demonstrated that AIP inhibited FBXO11-mediated ubiquitination of BCL6. Intriguingly, mice deficient for FBXO11 in their B cells show a phenotype that is the opposite of ours; namely, an increased percentage of GC B cells and DZ GC B cells. These mice are also more prone to developing lymphoproliferative disease (Schneider et al., 2016) . The DUB UCHL1 has been found to be expressed in GC B cells and lymphoma cells (Hussain et al., 2010) , but the functional relevance of this expression of UCHL1 has not been determined. We found that UCHL1 could deubiquitinate BCL6, but only in the presence of AIP, indicating that AIP regulated the function of UCHL1. The precise mechanism by which AIP regulates UCHL1 will be the focus of future research, but DUBs often require co-factors to function (Komander et al., 2009) .
AIP is a co-chaperone of HSP90 that can bind to proteins that control GC B cell phenotype, including c-MYC, STAT5, and nuclear factor kB (NF-kB), in addition to BCL6 (Cerchietti et al., 2009; Hertlein et al., 2010; Paul et al., 2013; Weigert et al., 2012) . We have not ruled out the possibility that AIP can regulate these molecules, as these might contribute to the phenotype we observe in Aip-deficient B cells. This is the focus of ongoing research.
Ubiquitin E3 ligases often work in close proximity to DUBs to provide precise control over substrate proteins (Komander et al., 2009) . Increased expression of the DUB UCHL1 has been associated with development of lymphoma and is a positive regulator of AKT signaling (Bedekovics et al., 2016; Hussain et al., 2010) , but in B cells, its substrates and how it is regulated have not been identified. We found UCHL1 to be a binding partner of AIP and BCL6, indicating that it might function to help maintain BCL6 expression in GC and DLBCL cells.
There is significant evidence that chaperones are important regulators of protein quality control, helping ubiquitin E3 ligases and DUBs recognize their target proteins (Kriegenburg et al., 2012; Lee et al., 2014; Manjarrez et al., 2014; Morales and Perdew, 2007; Perrody et al., 2016) . Chaperone molecules contribute to the pathobiology of cancers by protecting labile proteins from being degraded and supporting signaling pathways that cancer cells are dependent upon (Polier et al., 2013; Whitesell and Lindquist, 2005; Zong et al., 2015) . We found AIP to be predominantly expressed in DLBCL compared to other tumors and overexpressed in DLBCL biopsy samples compared to tonsil tissue, indicating that AIP might contribute to DLBCL pathology. Knockdown of AIP in DLBCL cells resulted in decreased viability of DLBCL cells, indicating that targeting AIP could be used as a potential treatment for DLBCL. How BCL6 expression is maintained is still not completely understood. The data presented here reveal that AIP is a positive regulator of BCL6 protein expression, which is commonly upregulated in B cell lymphomas, and show that AIP binds to an E3 ligase (FBXO11) and a DUB (UCHL1), both of which have been associated with DLBCL pathobiology. Therefore, AIP is a potential therapeutic target to treat DLBCLs.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Aip fl/fl (Jackson laboratories) and Ahr fl/fl mice (Li et al., 2011) were crossed with Rag1 Cre/+ mice (a kind gift from Brigitta Stockinger,
Crick Institute) to specifically delete Aip in Rag1 expressing cells (T and B cells) as previously described (Li et al., 2011) , and Cg1
Cre/+ mice (a kind gift from Dinis Calado, Crick Institute; Calado et al., 2012) to specifically delete Aip in GC B cells. Male and female mice were born to expected Mendelian ratios and had no signs of any abnormalities until they were used at 9-11 weeks of age. Male and female mice were randomly assigned to experimental groups. All mice were maintained in a barrier facility and all experiments were approved and performed adhered to Home Office regulations (Guidance on the Operation of Animals, Scientific Procedures Act, 1986) and Queen Mary University of London ethics committee on the use of animals for research. Genotyping was performed using the primers listed in Key Resources Table. Cell lines HEK293T (ATCC), OC1-LY7 (ATCC), SUDHL6, OC1-LY1, DoHH2, Karpas422, A20 (Barts Cancer Institute), human EBV (Herná ndezRamírez et al., 2016)
Tissue array Human DLBCL tissue microarray (33 patients, age range 23-86y). Sample collection approved by the local Human Ethics Committee.
METHOD DETAILS Immunizations
Mice were immunized in the peritoneum with either 2 3 10 9 fresh SRBCs (TSC Biosciences Ltd, UK) and 10 days later sacrificed as in Calado et al. (2012) . NP (4-hydroxy-3-nitrophenyl-acetyl) conjugated to Keyhole Limpet Hemocyanin (KLH) or to Ficoll (Biosearch Technologies, Petaluma, USA) and examined 14 days later (Capasso et al., 2010; García de Vinuesa et al., 1999) .
Collection and staining of tissues Mouse tissues were stained using primary antibodies (Key Resources Table) . Nuclei were detected using Hoechst 33258 and FITC was amplified using goat anti-FITC Alexa Flour 488 (Life Technologies). For AID staining a tertiary step of donkey anti-goat FITC (Jackson ImmunoResearch) was used. Slides were imaged using the Zeiss LSM 780 Confocal Microscope and Zeiss Axio Scan.Z1. Image analysis was performed using Zeiss Zen 2012 software to determine germinal center, follicular and spleen area. Plasma cells were counted by hand.
IgM stimulation of B cells
Spleen cells were stimulated with anti-mouse IgM (10mg/ml) (Jackson ImmunoResearch). At the end of the experiment, cells were immediately put on ice, fixed and permeabilized using and analyzed by flow cytometry for phosphorylated signaling molecules.
In vitro cell culture of B cells B cells were isolated by MACS isolation or cell sorting and 10 5 /well were stimulated with 1 mg/ml anti-CD40 (Jackson ImmunoResearch) and 25ng/ml IL-4 (eBioscience) and the cells examined 38, 72 and 96 hours after stimulation.
Flow cytometry
Single-cell suspensions of tissues were prepared by passing spleen and lymph nodes through a 70 mm cell strainer and incubated with anti-CD16/32 (2.4G2) to block non-specific binding and then stained with antibodies (Key Resources Table) . Cells were fixed and permeabilized using the Biolegend intracellular staining and permeabilization buffer according to the manufacturer's instructions. Samples were acquired on an LSR Fortessa (BD) and the data analyzed using FlowJo software version 9.3.1 (Tree Star, Inc, Ashland, USA).
Detection of sheep red blood cell-specific antibodies This was performed as described in Calado et al. (2012) . Serum from mice was serially diluted and incubated with SRBC for 20 minutes on ice washing in cold phosphate-buffered saline and staining the SRBCs with a phycoerythrin (FITC)-conjugated anti-mouse IgG antibody and the samples were analyzed by flow cytometry.
Western blotting
Cells were re-suspended in cold RIPA lysis buffer (50mM Tris-HCl, pH 8.0, 10% sodium deoxycholate, 10% SDS, 150mM NaCl, 5mM EDTA, pH 8.0), supplemented with a mixture of protease inhibitors (1mM phenylmethylsulphonyl fluoride, 10mM sodium fluoride, 1mM sodium vanadate, 1mg/mL Leupeptin, 2mg/ml Aprotinin, 1M B-glycer). Samples were separated by standard SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Protein extracts (40 mg total protein/lane) were fractionated on 8% SDS polyacrylamide gels and transferred to nitrocellulose membranes before being incubated with primary antibodies.
Immuno-precipitation HEK293T cells (ATCC) (0.5 3 10 6 ) were plated in 10cm dishes and the next day transfected with AIP and BCL6 epitope tagged plasmids using Fugene (Promega) according to the manufacturer's instructions. The next day, cells were washed with 1ml phosphatebuffered saline and lysed using lysis buffer (5M NaCl, 1M Tris, 75% glycerol, 0.5M, EDTA, NP-40, sodium fluoride, dH 2 O and sodium vanadate). Subsequently, the cell lysates underwent immune-precipitation executed under cold conditions (4 C) throughout. Cell lysates were subjected to an overnight incubation on a rotator with the primary antibody followed by a two-hour incubation with 50 mL of protein A and G agarose beads. Pellets were washed with 500 mL lysis buffer five times, re-suspended in 40 mL lysis buffer and 10 mL 4 3 SDS sample buffer. Samples were boiled at 95 C for 5 minutes and left to cool on ice to proceed with SDS-PAGE for immuno-blotting.
AIP staining of DLBCL tissue biopsies
Tissue microarrays containing either reactive lymph node (tonsil) or DLBCL samples from the Bart's Cancer Institute tissue bank were immuno-stained for AIP and tissue microarrays images were taken using an Olympus BX61 microscope and analyzed using Ariol software for the staining intensity of AIP.
Lentivirus production and transfection of B cells
Lentivirus was produced using the protocol described in Kutner et al. (2009) in accordance with institutional guidelines using lentivirus. ShRNAi sequences against human AIP were purchased from Dharmacon/GE Life sciences. Early passage OC1-LY7 cells (less than passage 10) (ATCC) grown in Iscove's Modified Dulbecco's Medium supplemented with 20% FBS, were transduced with lentivirus containing a scrambled sequence or shRNAi against AIP using the method described by Boulianne et al. (2017) . 2.5 3 10 5 OC1-LY7 cells were spin-oculated with 50 mL of lentivirus supernatants supplemented with 5mg/ml polybrene (Sigma) and spun for 90 minutes at 2300 rpm. After 4 hours, media was replaced with fresh media (Iscove's modified Dulbecco's Medium supplemented with 10% FBS) and 24 hours later the cells were examined. Transfection efficiency using green fluorescent protein was shown to be $85%.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using Prism software (Version 6). Un-paired two-tailed Student's t test, Mann-Whitney test and 2-way ANOVA test were used as appropriate. Significance was taken as p < 0.05. Statistical details of the experiments can be found in the Figure Legends and Results. Data are plotted as mean ± SEM with n the number of biological replicates. On figures significance is marked as * p < 0.05, ** p < 0.01, ***p < 0.001.
